IMMUTEP Ltd Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by IMMUTEP Ltd, a foreign private issuer headquartered in Sydney, Australia, on November 30, 2017. The filing primarily serves to incorporate by reference a registration statement on Form F-3 and to disclose a significant corporate event: the rebranding of the company from PRIMA BIOMED to IMMUTEP.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing regarding a name change and does not contain financial statements or performance data.
Material Changes
- Corporate Name Change: The registrant has officially changed its name from PRIMA BIOMED to IMMUTEP Ltd.
- Constitution Update: The filing includes the updated IMMUTEP Limited Constitution as an exhibit.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for management guidance, future outlook, specific risk factors, contingencies, or unusual items. The document focuses solely on the administrative update of the company's name and constitutional documents.
Key Facts for Investor Verification
- Verify the effective date of the name change from PRIMA BIOMED to IMMUTEP Ltd in market data systems.
- Confirm that the updated Constitution (Exhibit 99.2) aligns with the company's current governance structure.
- Review the referenced Form F-3 (File No. 333-221021) for detailed financial information, as this Form 6-K does not contain financial metrics.